Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus

https://doi.org/10.1016/0168-8227(92)90074-2Get rights and content

Abstract

We examined the response of plasma islet amyloid polypeptide (IAPP) to an oral glucose load in non-obese and obese subjects with normal glucose tolerance or impaired glucose tolerance (IGT), and in non-obese patients with non-insulin-dependent diabetes mellitus (NIDDM). Plasma IAPP response to intravenous glucagon injection in NIDDM patients was also studied. Plasma IAPP concentration was determined by a sensitive and specific radioimmunoassay. Basal levels of plasma IAPP in non-obese subjects with normal glucose tolerance, IGT and NIDDM were not significantly different from each other. Non-obese subjects with IGT showed delayed and higher plasma IAPP response to oral glucose load compared to normal non-obese subjects. In NIDDM patients, IAPP response to glucose was delayed and lower when compared to normal non-obese subjects. Basal levels of plasma IAPP in normal obese subjects and obese subjects with IGT were significantly higher than those in normal non-obese subjects. Plasma IAPP response to glucose load in these obese subjects was higher than that in normal non-obese subjects. Plasma IAPP response was decreased in diabetic patients treated with diet, oral hypoglycemic agents and insulin in that order. We conclude that the secretion of IAPP is reduced with progression of NIDDM, although it appears to be rather augmented in IGT compared to normal non-obese subjects.

References (16)

  • M. Nakazato et al.

    Islet amyloid polypeptide, a novel pancreatic peptide, is a circulating hormone secreted under glucose stimulation

    Biochem. Biophys. Res. Commun.

    (1990)
  • M. Nakazato et al.

    Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration

    Biochem. Biophys. Res. Commun.

    (1989)
  • P. Westermark et al.

    Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type-2 (non-insulin-dependent) diabetic and non-diabetic individuals

    Diabetologia

    (1987)
  • C.F. Howard

    Longitudinal studies on the development of diabetes in individual Macaca nigra

    Diabetologia

    (1986)
  • P. Westermark et al.

    Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells

  • G.J.S. Cooper et al.

    Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

  • A. Lukinius et al.

    Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets

    Diabetologia

    (1989)
  • T. Mitsukawa et al.

    Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration

    Diabetes

    (1990)
There are more references available in the full text version of this article.

Cited by (0)

View full text